[Retracted] Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">miRNA</td><td class="align_center">Sequence</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">hsa-miR-155-5p</td><td class="align_center">UUAAUGCUAAUCGUGAUAGGGGUU</td></tr><tr><td class="align_left">hsa-let-7a-5p</td><td class="align_center">UGAGGUAGUAGGUUGUAUAGUU</td></tr><tr><td class="align_left">hsa-miR-146a-3p</td><td class="align_center">CCUCUGAAAUUCAGUUCUUCAG</td></tr><tr><td class="align_left">hsa-miR-181a-3p</td><td class="align_center">ACCAUCGACCGUUGAUUGUACC</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

BioMed Research International

tab2

Table 2

Table 2: [Retracted] Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia 